BioBusiness 2012

BioBusiness 2012 - The leading high-level BioPharma strategy and bio-partnering conference This leading bio-partnering conference is THE only place in London where VP to CEO level delegates from small biotech's through to top 10 pharma's and key financers behind innovation will gather to discuss high level strategy and build relationships. Forward thinking companies will come to make their next big deal. We've listened to our delegates and BioBusiness 2012 returns to London in January with a revamped, strategically focused programme and speaker cohort based on your industry feedback! Confirmed Speakers Alan Moodie, Vice President, Business Development, GlaxoSmithKline Jackie Hunter, Founder and Chief Executive Officer, OI pharma partners Alan Palkowitz, Vice President, Discovery Chemistry, Eli Lilly Jørgen Thorball, Managing Partner, XOventure Life Science Experts Andrew Sandham, Chairman & CEO, Kymab Kimberly Brue, Senior Director, Alliance Management, Biogen Idec Axel Polack, General Manager, TVM Capital* Mike Ward, Editor, Scrip Intelligence Bernard Munos, Founder, InnoThink Center for Research in Biomedical Innovation Malcolm Weir, Chief Executive Officer, Heptares Therapeutics Carole Nuechterlein, Head of Venture Investments, Roche Venture Funds Margaret Beer, Senior Director & Head, Licensing & External Research, Merck Daphne Zohar, Founder, Managing Partner, PureTech Ventures* Martino Picardo, CEO, Stevenage Bioscience Catalyst David Phillips, Partner, SR One Melanie Lee, CEO, Syntaxin Denise Goode, Executive Transaction Director - Strategic Planning & Business Development, AstraZeneca Nicki Thompson, Director, Business Development, Alternative Discovery and Development, GlaxoSmithKline Deborah Harland, Partner, SR One Onno van de Stolpe, Chief Executive Officer, Galapagos Denise Pollard-Knight, CEO, Phase4 Ventures Peter Nolan, Executive Director, SVP Commercial Development, Oxford BioMedica Francesco De Rubertis, Life Sciences Partner, Index Ventures Simon Haworth, MD, BSG Team Ventures Gertjan Bartlema, Executive Director Marketing & Sales Excellence, Celgene Steven Holtzman, Executive Vice President, Corporate Development, Biogen Idec Graeme Martin, President and CEO, Takeda Research Investment www.biobusiness-conference.com